Published in Medical Letter on the CDC and FDA, February 3rd, 2008
Plucinski brings seven years of quality assurance experience to MBR, including more than three years as an investigator with the FDA. Jim has experience working in both GMP and GLP environments, as well as conducting GMP and GLP audits of both pharmaceutical and medical device firms, and GCP audits of clinical investigators. Prior to MBR, Plucinski worked as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.